The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Cost-effectiveness of atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

Kishan  Patel

No Relationships to Disclose

Stacey  Stein

Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; QED Therapeutics

Janki  Luther

No Relationships to Disclose

Scott F.  Huntington

Honoraria - AstraZeneca; Pharmacyclics; Seagen

Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Flatiron Health; Genentech; Janssen; Novartis

Research Funding - Celgene; Debiopharm Group; DTRM; TG Therapeutics

Travel, Accommodations, Expenses - Bayer; Celgene